• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Medical Humor: 8 Ridiculous Sentences

Slideshow

And now, back by popular demand ... 8 medical sentences that could benefit from a little editing.

slideshow image

Keeping it on the light side, here are some notable sentences submitted by clinicians to this website that cry out for editing. Spoiler alert: "The single most important stumbling block to a total cure for children."

Related Videos
Impressions From Case 2
Impressions From Case 2
The "Ugly Face" of Long COVID: A Conversation with Steven Flanagan, MD, President-elect, AAPM&R
The "Ugly Face" of Long COVID: A Conversation with Steven Flanagan, MD, President-elect, AAPM&R
Persistent Vaccine Skepticism Can Erode Clinician Confidence in their Own Recommendations
Persistent Vaccine Skepticism Can Erode Clinician Confidence in their Own Recommendations
"Vaccination is More of a Marathon than a Sprint"
"Vaccination is More of a Marathon than a Sprint, so Keep Listening”
Factors to Consider When Treating Acute Pain
Factors to Consider When Treating Acute Pain
Diagnosis of Acute Pain
Diagnosis of Acute Pain
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Booster Fatigue, Vaccines are for Kids, and Other Obstacles to Adult Immunization in Primary Care
Vaccine Hesitancy: How COVID-19 Changed the Tone, with Gretchen LaSalle, MD
Vaccine Hesitancy: How COVID-19 Changed the Tone, with Gretchen LaSalle, MD
Impact of COVID-19 on Acute Pain Management
Impact of COVID-19 on Acute Pain Management
Pathogenesis and Causes of Acute Pain
Pathogenesis and Causes of Acute Pain
Related Content
ADA Standards of Care for Overweight and Obesity to Debut at 2025 Scientific Sessions / ©design36/shutterstock.com

ADA Standards of Care for Overweight and Obesity to Debut at 2025 Scientific Sessions

Grace Halsey
June 20th 2025
Article

The ADA unveils the association's first Standards of Care for Overweight and Obesity, with a chapter on weight stigma and bias one of the first released.

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

Sydney Jennings
June 11th 2025
Podcast

Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.

Dual GLP-1/GLP-2 Agonist Dapiglutide Achieves 11.6% Mean Weight Loss at 28 Weeks in Phase 1b Trial

Dual GLP-1/GLP-2 Agonist Dapiglutide Achieves 11.6% Mean Weight Loss at 28 Weeks in Phase 1b Trial

Sydney Jennings
June 20th 2025
Article

The investigational dual GLP-1/GLP-2 agonist led to 11.6% weight loss over 28 weeks with no lifestyle changes, showing strong safety and tolerability in the trial.

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

Sydney Jennings
June 4th 2025
Podcast

Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.

/ image credit ©Billion Photos/stock.adobe.com

Teledermatology-Dermoscopy Program Could Help Reduce Inequities in Skin Cancer Screening

Grace Halsey
June 20th 2025
Article

A student-led teledermatology initiative that identified skin lesions in underserved communities could be a scalable model for early skin cancer detection and care.

Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision / image credit ©Waldenmarus/stock.adobe.com

Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision

Killian Meara
June 19th 2025
Article

The only pre-exposure prophylaxis approved for twice-a-year dosing, lenacapavir "could be the transformative PrEP option we’ve been waiting for," one expert said.

© 2025 MJH Life Sciences

All rights reserved.